Vascular Access Device Market Size, Share & Trends Analysis Report By Treatment Type (Reconstructive Vaginal Rejuvenation, Cosmetic Vaginal Rejuvenation), By Type (Surgical, Non-surgical), By Application (Incontinence, Aesthetic Purposes, Aging And Childbirth, Others), By Age Category (Below 20/ 20-30, 30-40, 40 And Above), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast Till 2031. The report offers the value (in USD Billion) for the above segments.

Market Overview:

The market for Vascular Access Device was valued at approximately USD 1.89 Billion in 2023. Over the course of the forecast period (2024–2031), the market is expected to develop at a compound annual growth rate (CAGR) of 5%, reaching a value of USD 2.75 Billion by 2031.

Despite the harm caused by COVID-19, a slight increase in the vascular access device market is anticipated over the course of the projected period. Patient demographics include the aging of the world's population, the rising cancer incidence, and the prevalence of metabolic, respiratory, and cardiovascular problems will have a significant impact on market growth over the course of the projection period. This implies that during their course of therapy, more patients will need to use a vascular access device.

The industry's growth is also significantly influenced by market categories like CVCs, PICCs, and Short PIVCs. More specifically, during the course of the forecast period, it is expected that PICC sales will surpass those of CVC devices, which will significantly impede the growth of the CVC market to some degree. The application of pricey power-injectable, secure, anti-thrombogenic, and antibacterial technologies that lower complication rates will also be advantageous to the industry.

The market for vascular access devices has suffered as a result of the global COVID-19 outbreak. Furthermore, the industry's revenues increased in the years that followed despite a substantial drop in vascular access gadget sales overall in 2020. This was due to rising adoption of dialysis, PICC, and CVC catheters as a result of an increase in demand for vascular devices that are used in the care and management of COVID-19 associated patients.

Additionally, the market is bolstered by the growing need for solutions that can reduce problem rates due to increased awareness of the costs associated with catheter-related difficulties in healthcare facilities. Several recent clinical studies have demonstrated that one major contributing factor to the issues may be inappropriate use and maintenance of vascular access devices. Offering online or in-person training programs could help manufacturers set their products apart from those of their rivals and promote brand loyalty. A couple of these effective initiatives include the Clinical Training programs from BD and the Teleflex Academy program from Teleflex Medical.

Market Dynamics:

Market Drivers:

Rising Incidence of Chronic Diseases

• The growing prevalence of chronic illnesses such cancer, renal failure, diabetes, & cardiovascular diseases is driving the vascular access device market. Patients with long-term medical issues may need continuous vascular access for parenteral nourishment, hemodialysis, chemotherapy, and drug delivery. Vascular access devices enable the safe and reliable administration of drugs, fluids, and blood products as well as the removal of blood samples for diagnostic testing. Examples of these devices include central venous catheters, implantable ports, and peripherally inserted central catheters (PICCs). The need for vascular access devices is anticipated to rise as the incidence of persistent illnesses continues to rise globally as a result of aging populations, changing lifestyles, and other factors. These patients will require long-term venous access for medical treatments.

Technological Advancements and Product Innovations

• Vascular access devices are driven by continuous technology advancements and product breakthroughs that improve the equipment's usability, safety, and efficacy. In order to create innovative materials, designs, and methods for vascular access devices that lower the risk of problems like infection, thrombosis, & catheter-related bloodstream infections (CRBSIs), manufacturers are spending money on research and development. In order to lower the risk of infections and thrombotic problems, antimicrobial coatings, biofilm-resistant polymers, and anti-thrombogenic surfaces, for instance, help reduce microbial colonization & clot formation on catheter surfaces. Furthermore, advancements in vascular access device placement accuracy and success rates—such as sutureless securement devices, tip-positioning systems, and ultrasound-guided insertion techniques—improve patient safety and comfort. The desire for safer, more dependable, and easier-to-use vascular access solutions in clinical settings is satisfied by the availability of cutting-edge and inventive vascular access devices, which propels market expansion.

Market Trends:

Shift towards Minimally Invasive Procedures

• The growing use of less invasive vascular access procedures is driving the market for vascular access devices. Peripherally inserted central catheters (PICCs) and ultrasound-guided catheter placement are two examples of minimally invasive techniques that have several advantages over traditional medical methods, such as shorter recovery times, less trauma, and a decreased risk of complications like bleeding and infection. Because of these techniques' increased safety, effectiveness, and patient comfort, both patients and healthcare professionals favor them. Additionally, difficult patient populations like children, the elderly, and critically ill patients—who might not be good candidates for conventional surgical interventions—can have vascular access thanks to minimally invasive procedures. The move toward minimally invasive procedures is anticipated to propel market expansion and influence the use of vascular access devices as healthcare systems emphasize patient safety, effectiveness, and cost-effectiveness.

Emphasis on Infection Prevention and Control

• A growing focus on infection prevention and control strategies to lower the frequency of catheter-related bloodstream infections (CRBSIs) along with other healthcare-associated infections (HAIs) is being placed on the vascular access device industry. Patients who have vascular access devices are at a higher risk of morbidity and mortality due to CRBSIs, which can result in longer hospital stays, higher healthcare expenses, and worse patient outcomes. Strict infection control methods, including as hand hygiene practices, catheter site care recommendations, and antibiotic stewardship programs, are being implemented by healthcare providers and regulatory bodies in response to increased concerns about healthcare-associated infections (HAIs). In order to lower the danger of microbial colonization and infection, manufacturers are also creating vascular access devices with integrated infection prevention features, such as closed catheter systems, dressings coated with chlorhexidine, and antimicrobial coatings. The need for safer and more efficient vascular access devices that assist reduce the incidence of CRBSIs and enhance patient outcomes is driven by the emphasis on prevention and control of infections strategies.

Market Restraining Factors:​

Complications and Risks Associated with Vascular Access Devices

• The dangers and potential issues that come with using vascular access devices are what drive the market for these devices. Vascular access devices still have some dangers, including the possibility of infection, thrombosis, catheter-related bloodstream infections (CRBSIs), incorrect catheter positioning, and mechanical issues including catheter dislodgement or breakage, even with the latest technological breakthroughs and product innovations. In severe circumstances, these issues may result in mortality as well as unfavorable patient outcomes and higher healthcare expenses and hospital stays. In order to reduce the risk of difficulties, healthcare practitioners must carefully consider the advantages and disadvantages of employing vascular access devices and put in place the necessary surveillance and prevention measures. Vascular access device adoption and use may be cautious as a result of patients' and healthcare professionals' awareness of these dangers, which might potentially restrain market growth.

Key Industry Developments:

• In July 2022, B. Braun Medical Inc. (B. Braun) has introduced the Introcan Safety 2 IV Catheter, which is designed for one-time blood control. By lowering the chance of needlestick injuries and blood exposure, B. Braun's most recent invention, the Introcan Security 2 IV Catheter, helps physicians access IVs more safely.
• In May 2022, The US Food and Drug Administration (FDA) has approved Access Vascular, Inc. (AVI)'s HydroPICC Dual-Lumen catheter under 510(k) guidelines. These devices, which are made of the same exclusive hydrophilic biological material as AVI's single-lumen HydroPICC and HydroMID® tubes, have been shown in recent studies to significantly reduce problems such occlusions, replacements, deep vein thrombosis, and phlebitis.

Report Coverage:

The report will cover the qualitative and quantitative data on the global Vascular Access Device Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations:

Vascular Access Device Market Players Analysis:

• Teleflex Medical
• BD
• Braun   
• Smith’s Medical (ICU Medical, Inc)
• Cook Medical
• AngioDynamics
• Medtronic
• Medical Components, Inc.
• Cook Medical
• Terumo Medical Corporation
• Access Vascular, Inc.

Vascular Access Device Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2024-2031 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Vascular Access Device Market Segmentation Analysis:

By Treatment Type

• Reconstructive Vaginal Rejuvenation
• Cosmetic Vaginal Rejuvenation

By Type

• Surgical
• Non-surgical

By Application

• Incontinence
• Aesthetic Purposes
• Aging And Childbirth
• Others

By Age Category

• Below 20/ 20-30
• 30-40
• 40 And Above

The report also helps in understanding Global Vascular Access Device Market dynamics, structure by analyzing the market segments, and project the Global Vascular Access Device Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Vascular Access Device Market make the report investor’s guide.

Segmentation Analysis:

The market is divided into segments based on By Product, By End-Use, By Application, By Age Category.

By Product

Based on the Product of the market is segmented into Surgical, Non-surgical.

The short peripheral intravenous catheters market accounted for about 40% of total revenue in 2022. Furthermore, during the projected period, the market for brief PIVCs will account for a disproportionately large share of revenue, primarily because consumers choose the more costly and secure short PIVCs over more common devices.

Furthermore, due to the Michigan Appropriateness Guide to Intravenous Catheters (MAGIC) suggestions, usage patterns have changed recently, especially in the United States. This has caused vascular access specialists to depart from the historical access system, which has significantly reduced the uptake of PICCs.

Conversely, it is projected that the CVC market will occupy the second-leading position in the market. However, there is significant pressure from rival devices like PICCs and implanted ports to limit the use of CVC to some extent.

By End-Use 

Based on the End-Use size of the market is Segmented into Incontinence, Aesthetic Purposes, Aging And Childbirth, Others.

In 2022, the hospital-based segment held a dominant market share of almost 50%. Hospitals have a large supply of highly qualified and experienced healthcare workers, which will probably allow the sector to maintain its dominance in the years to come. The finest treatment and improved results for vascular access are provided by skilled and experienced staff in healthcare institutions such as hospitals and dialysis clinics. Many factors are anticipated to propel the sector, one of which is the growing focus of businesses on creating autonomous vascular access facilities.

Regional Snapshots:

By region, Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. North America dominated the market in 2022 with a revenue share of more than 58%. The market in the area is expanding as a result of the presence of substantial rivals, a favorable reimbursement program, and a sizeable government investment in the creation of cutting-edge medical equipment. Other drivers of industry expansion include government initiatives, rising healthcare costs, and growing disposable income.

Asia Pacific economy is expected to accelerate during the projection period. Additionally, the vascular access device market is anticipated to be stimulated by regional distributors who have a competitive advantage and well-established local contacts. Foreign competitors, for instance, collaborate with regional distributors to extend their operations in the Asia Pacific region. AngioDynamics, for example, has a distribution arrangement with Medical Specialties, according a June 2017 press release from Medical Specialties Australasia. Over 80% of Australia's population lives on the east coast, where AngioDynamics sells its BioFlo and Xcela PICCs through Medical Specialties. This agreement will increase PICC sales for AngioDynamics in Australia.

Vascular Access Device Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S.
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report:

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.

The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase:

To gain insightful analyses of the Vascular Access Device market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the Vascular Access Device market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the Vascular Access Device market. Besides the standard structure reports, we also provide custom research according to specific requirements.

Research Scope of Vascular Access Device Market:

• Historic year: 2019- 2022
• Base year: 2022
• Forecast: 2024 to 2031
• Representation of Market revenue in USD Million

Vascular Access Device Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: